99% Savings - Buy Just @1 Rs X
Rapilif D 4/0.5 Capsule is a commercial drug that is prescribed in the form of Capsule. Other than this, Rapilif D 4/0.5 Capsule has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Rapilif D 4/0.5 Capsule is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Rapilif D 4/0.5 Capsule as well, which are listed below. These side effects of Rapilif D 4/0.5 Capsule are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Rapilif D 4/0.5 Capsule is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Rapilif D 4/0.5 Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rapilif D 4/0.5 Capsule related warnings section.
Rapilif D 4/0.5 Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease as it can result in adverse effects. Other contraindications of Rapilif D 4/0.5 Capsule have been discussed in the sections ahead.
Drug reaction of Rapilif D 4/0.5 Capsule with other medicines has been reported. See below for a complete list.
You should also be aware that Rapilif D 4/0.5 Capsule is safe while driving, and is addiction.
Rapilif D 4/0.5 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Geriatric |
|
Is the use of Rapilif D 4/0.5 Capsule safe for pregnant women?
Rapilif D has many dangerous side effects in pregnant women. If you are pregnant, do not consume Rapilif D without medical advice.
Is the use of Rapilif D 4/0.5 Capsule safe during breastfeeding?
Rapilif D should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Rapilif D 4/0.5 Capsule on the Kidneys?
There are no side effects of Rapilif D on the kidneys.
What is the effect of Rapilif D 4/0.5 Capsule on the Liver?
Rapilif D can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Rapilif D 4/0.5 Capsule on the Heart?
You can take Rapilif D without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Rapilif D 4/0.5 Capsule unless your doctor advises you to do so -
Is this Rapilif D 4/0.5 Capsule habit forming or addictive?
Rapilif D 4/0.5 Capsule is not addictive in nature.
Interaction between Food and Rapilif D 4/0.5 Capsule
Information is not available on the interaction of any foods with Rapilif D 4/0.5 Capsule, due to a lack of research on this.
Interaction between Alcohol and Rapilif D 4/0.5 Capsule
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rapilif D 4/0.5 Capsule.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rapaflo® (silodosin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1137-1138
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)